Article info

Download PDFPDF

Original research
Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020

Authors

  • Katinka Albrecht Epidemiology and Health Services Research, German Rheumatism Research Centre, Berlin, Germany PubMed articlesGoogle scholar articles
  • Anja Strangfeld Epidemiology and Health Services Research, German Rheumatism Research Centre, Berlin, GermanyDepartment of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Ursula Marschall Department Medicine and Health Services Research, BARMER Institute for Health System Research, Wuppertal, Germany PubMed articlesGoogle scholar articles
  • Johanna Callhoff Epidemiology and Health Services Research, German Rheumatism Research Centre, Berlin, GermanyInstitute for Social Medicine, Epidemiology and Health Economics, Charité Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Katinka Albrecht; albrecht{at}drfz.de
View Full Text

Citation

Albrecht K, Strangfeld A, Marschall U, et al
Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020

Publication history

  • Received October 7, 2022
  • Accepted January 11, 2023
  • First published January 20, 2023.
Online issue publication 
January 20, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.